“Lazarus Response” to Olaparib in a Virtually Chemonaive Breast Cancer Patient Carrying Gross BRCA2 Gene Deletion

This report describes an estrogen receptor-positive breast cancer patient, who relapsed at two and a half years after the completion of adjuvant chemotherapy while being on the aromatase inhibition. Based on the clinical evidence for potential sensitivity of the tumor to hormone ablation, everolimus...

Descripción completa

Detalles Bibliográficos
Autores principales: Moiseyenko, Vladimir M, Chubenko, Vyacheslav A, Moiseyenko, Fedor V, Zagorskaya, Lyudmila A, Zaytseva, Yuliya A, Gesha, Nataliya E, Zykov, Evgeny N, Ni, Valeriya I, Preobrazhenskaya, Elena V, Sokolenko, Anna P, Imyanitov, Evgeny N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890964/
https://www.ncbi.nlm.nih.gov/pubmed/29651367
http://dx.doi.org/10.7759/cureus.2150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890964/
https://www.ncbi.nlm.nih.gov/pubmed/29651367
http://dx.doi.org/10.7759/cureus.2150

Ejemplares similares